About Icatibant
            
            Class: | Peptide bradykinin B2 receptor antagonist  
Use: | Treatment of acute attacks of hereditary angioedema in adults and adolescents aged 12 years and older  
Adult dose: | 30 mg subcutaneously, may repeat after 6 hours if symptoms persist; maximum of 3 doses in 24 hours  
Pediatric dose: | Safety and efficacy not established in patients under 12 years of age  
Side effects: | Injection site reactions, headache, nausea, abdominal pain, diarrhea, dizziness  
Contraindications: | Hypersensiti
         
        
            
                
                
                    
                        Drug Class
                    
                    Peptide bradykinin B2 receptor antagonist
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of acute attacks of hereditary angioedema in adults and adolescents aged 12 years and older
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator (2°C to 8°C); do not freeze; may be stored at room temperature (up to 25°C) for up to 3 months
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: SHIRE PHARMACEUTICALS IRELAND LIMITED, IRELAND
                    
                    
                    Package Size
                    3ml Prefilled syringe
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 9368.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        30 mg subcutaneously, may repeat after 6 hours if symptoms persist; maximum of 3 doses in 24 hours
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in patients under 12 years of age
                    
                 
                
                
                    
                        Side Effects
                    
                    Injection site reactions, headache, nausea, abdominal pain, diarrhea, dizziness
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to icatibant or any component of the formulation; severe hepatic impairment
         
        
        
            
                Important Warnings
            
            Risk of hypersensitivity reactions; monitor for signs of anaphylaxis; not for prophylactic use; use with caution in patients with moderate hepatic impairment
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.